bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Mar 6, 2026, 4:00 PM EST
1.012
-0.028 (-2.72%)
After-hours: Mar 6, 2026, 7:12 PM EST

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5141413--
Market Cap Growth
-62.99%2.64%2.98%---
Enterprise Value
-2.3613.8812.112.2500
Last Close Price
1.0427.3044.1048.00--
PE Ratio
--1.21-1.62-0.88--
PS Ratio
0.681.515.452792.02--
PB Ratio
0.405.452.841.21--
P/TBV Ratio
0.094.242.650.65--
P/FCF Ratio
--1.93-2.28-3.13--
P/OCF Ratio
--1.95-2.29-3.29--
EV/Sales Ratio
-1.484.78468.06--
EV/EBITDA Ratio
--1.66-1.57-0.56--
EV/EBIT Ratio
--1.55-1.52-0.56--
EV/FCF Ratio
--1.89-2.00-0.52--
Debt / Equity Ratio
0.030.310.230.02-0.96-0.89
Debt / EBITDA Ratio
-0.07-0.18-0.20-0.06-5.16-3.87
Debt / FCF Ratio
-0.08-0.20-0.26-0.06-5.55-4.53
Net Debt / Equity Ratio
-0.780.15-0.26-1.01-0.63-0.66
Net Debt / EBITDA Ratio
0.71-0.050.162.79-4.54-3.84
Net Debt / FCF Ratio
0.82-0.050.212.60-4.88-4.49
Asset Turnover
0.751.270.250.0000
Inventory Turnover
155.59259.63144.930.17--
Quick Ratio
3.440.721.6210.030.100.01
Current Ratio
3.650.871.7710.500.110.01
Return on Equity (ROE)
-256.24%-242.44%-99.84%2319.94%55.56%96.50%
Return on Assets (ROA)
-114.97%-121.37%-77.95%-58.82%-275.96%-647.28%
Return on Invested Capital (ROIC)
-417.44%-268.21%-450.95%430.89%154.95%304.85%
Return on Capital Employed (ROCE)
-164.85%-190.85%-93.71%1477.98%19.56%34.70%
Earnings Yield
-318.57%-82.42%-61.90%-113.13%--
FCF Yield
-183.87%-51.81%-43.89%-32.00%--
Buyback Yield / Dilution
-85.89%-40.90%0.00%-103.02%--
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q